Optimal dose of candesartan for renoprotection in type 2 diabetic patients with nephropathy: a double-blind randomized cross-over study (Q44262753)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimal dose of candesartan for renoprotection in type 2 diabetic patients with nephropathy: a double-blind randomized cross-over study |
scientific article |
Statements
1 reference
Optimal dose of candesartan for renoprotection in type 2 diabetic patients with nephropathy: a double-blind randomized cross-over study (English)
1 reference
Kasper Rossing
1 reference
Per K Christensen
1 reference
Birgitte V Hansen
1 reference
Bendix Carstensen
1 reference
Hans-Henrik Parving
1 reference
1 January 2003
1 reference
1 reference
Identifiers
1 reference